Elevations of t-Tau and p-Tau in the CSF are biomarkers of tauopathy in AD and they correlated well with intracerebral AD pathology, while decreases of Aβ1-42 in the CSF are inversely proportional to amyloid in the brain (Reitz, 2012). Here, MAPT is linked to Alzheimer disease.